E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/21/2006 in the Prospect News Emerging Markets Daily.

Israel's Elbit Medical Imaging to issue NIS 350 million in debentures

By Reshmi Basu

New York, Feb. 21 - Elbit Medical Imaging Ltd. plans to sell two series of unsecured non-convertible debentures for up to NIS 350 million via a private placement.

The first series will consist of NIS 294 million of bonds, which will bear an interest rate of 6%.

The second series will consist of NIS 56 million of series B debentures, which will bear interest at a rate of Libor plus 265 basis points.

Additionally, the issuer will issue NIS 44 million series B debentures to one of its subsidiaries.

Midroog Ltd., an affiliate of Moody's Investors Services, has given an A2 rating to the issuance.

The Tel Aviv-based company is engaged principally in the development of commercial and entertainment centers in central and eastern Europe.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.